IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $47,000 | -21.7% | 1,000 | 0.0% | 0.02% | -4.0% |
Q4 2019 | $60,000 | 0.0% | 1,000 | 0.0% | 0.02% | -7.4% |
Q3 2019 | $60,000 | -6.2% | 1,000 | 0.0% | 0.03% | -6.9% |
Q2 2019 | $64,000 | -21.0% | 1,000 | 0.0% | 0.03% | -23.7% |
Q1 2019 | $81,000 | +50.0% | 1,000 | 0.0% | 0.04% | +35.7% |
Q4 2018 | $54,000 | +3.8% | 1,000 | 0.0% | 0.03% | +16.7% |
Q3 2018 | $52,000 | +23.8% | 1,000 | 0.0% | 0.02% | +14.3% |
Q2 2018 | $42,000 | -4.5% | 1,000 | 0.0% | 0.02% | -4.5% |
Q1 2018 | $44,000 | -12.0% | 1,000 | 0.0% | 0.02% | -12.0% |
Q4 2017 | $50,000 | -2.0% | 1,000 | 0.0% | 0.02% | -3.8% |
Q3 2017 | $51,000 | 0.0% | 1,000 | 0.0% | 0.03% | -3.7% |
Q2 2017 | $51,000 | +27.5% | 1,000 | 0.0% | 0.03% | +12.5% |
Q1 2017 | $40,000 | -16.7% | 1,000 | 0.0% | 0.02% | -17.2% |
Q4 2016 | $48,000 | +29.7% | 1,000 | 0.0% | 0.03% | +26.1% |
Q3 2016 | $37,000 | +60.9% | 1,000 | 0.0% | 0.02% | +53.3% |
Q2 2016 | $23,000 | -43.9% | 1,000 | 0.0% | 0.02% | -46.4% |
Q1 2016 | $41,000 | -33.9% | 1,000 | 0.0% | 0.03% | -39.1% |
Q4 2015 | $62,000 | – | 1,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |